These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16157204)

  • 1. Cytogenetic findings in clear cell chondrosarcoma.
    Nishio J; Reith JD; Ogose A; Maale G; Neff JR; Bridge JA
    Cancer Genet Cytogenet; 2005 Oct; 162(1):74-7. PubMed ID: 16157204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic and spectral karyotype analyses of benign and malignant cartilage tumours.
    Sjögren H; Orndal C; Tingby O; Meis-Kindblom JM; Kindblom LG; Stenman G
    Int J Oncol; 2004 Jun; 24(6):1385-91. PubMed ID: 15138578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
    Tallini G; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Sciot R; Van den Berghe H; Vanni R; Willén H
    J Pathol; 2002 Feb; 196(2):194-203. PubMed ID: 11793371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors.
    Sawyer JR; Swanson CM; Lukacs JL; Nicholas RW; North PE; Thomas JR
    Cancer; 1998 Feb; 82(3):474-83. PubMed ID: 9452264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous interphase cytogenetic analysis and fluorescence immunophenotyping of dedifferentiated chondrosarcoma. Implications for histopathogenesis.
    Bridge JA; DeBoer J; Travis J; Johansson SL; Elmberger G; Noel SM; Neff JR
    Am J Pathol; 1994 Feb; 144(2):215-20. PubMed ID: 8311109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translocation der(13;21)(q10;q10) in skeletal and extraskeletal mesenchymal chondrosarcoma.
    Naumann S; Krallman PA; Unni KK; Fidler ME; Neff JR; Bridge JA
    Mod Pathol; 2002 May; 15(5):572-6. PubMed ID: 12011263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytogenetic changes in low grade central osteosarcomas].
    Werner M; Rieck J; Delling G
    Verh Dtsch Ges Pathol; 1998; 82():189-94. PubMed ID: 10095432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Der(16)t(1;16)(q21;q13) as a secondary structural aberration in yet a third sarcoma, extraskeletal myxoid chondrosarcoma.
    Day SJ; Nelson M; Rosenthal H; Vergara GG; Bridge JA
    Genes Chromosomes Cancer; 1997 Dec; 20(4):425-7. PubMed ID: 9408761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
    Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. t(9;22)(q22-31;q11-12) is a consistent marker of extraskeletal myxoid chondrosarcoma: evaluation of three cases.
    Sciot R; Dal Cin P; Fletcher C; Samson I; Smith M; De Vos R; Van Damme B; Van den Berghe H
    Mod Pathol; 1995 Sep; 8(7):765-8. PubMed ID: 8539235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative genomic hybridization in cartilaginous tumors.
    Ozaki T; Wai D; Schäfer KL; Lindner N; Böcker W; Winkelmann W; Dockhorn-Dworniczak B; Poremba C
    Anticancer Res; 2004; 24(3a):1721-5. PubMed ID: 15274346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic profiling of chondrosarcoma: chromosomal patterns in central and peripheral tumors.
    Hallor KH; Staaf J; Bovée JV; Hogendoorn PC; Cleton-Jansen AM; Knuutila S; Savola S; Niini T; Brosjö O; Bauer HC; Vult von Steyern F; Jonsson K; Skorpil M; Mandahl N; Mertens F
    Clin Cancer Res; 2009 Apr; 15(8):2685-94. PubMed ID: 19336518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clear cell sarcoma case report: complex karyotype including t(12;22) in primary and metastatic tumor.
    Henkle CT; Hawkins AL; McCarthy EF; Griffin CA
    Cancer Genet Cytogenet; 2004 Feb; 149(1):63-7. PubMed ID: 15104285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Array-comparative genomic hybridization of central chondrosarcoma: identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations.
    Rozeman LB; Szuhai K; Schrage YM; Rosenberg C; Tanke HJ; Taminiau AH; Cleton-Jansen AM; Bovée JV; Hogendoorn PC
    Cancer; 2006 Jul; 107(2):380-8. PubMed ID: 16779802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clear cell sarcoma associated with multiple pulmonary metastases with structural and numerical karyotypic changes.
    Kato N; Mizuno O; Tamura A; Yamanaka Y; Tanimura S; Minakawa H
    Clin Exp Dermatol; 2004 Nov; 29(6):614-6. PubMed ID: 15550135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic findings in 19 malignant bone tumors.
    Ozisik YY; Meloni AM; Peier A; Altungoz O; Spanier SS; Zalupski MM; Leong SP; Sandberg AA
    Cancer; 1994 Oct; 74(8):2268-75. PubMed ID: 7922978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dedifferentiated chondrosarcoma with t(9;22)(q34;q11-12).
    Tarkkanen M; Wiklund T; Virolainen M; Elomaa I; Knuutila S
    Genes Chromosomes Cancer; 1994 Feb; 9(2):136-40. PubMed ID: 7513544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pericentromeric inversion, inv (6)(p25q13), is a novel diagnostic marker in chondromyxoid fibroma.
    Granter SR; Renshaw AA; Kozakewich HP; Fletcher JA
    Mod Pathol; 1998 Nov; 11(11):1071-4. PubMed ID: 9831204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic analysis of a low-grade secondary peripheral chondrosarcoma arising in synovial chondromatosis.
    Kyriazoglou AI; Rizou H; Dimitriadis E; Arnogiannaki N; Agnantis N; Pandis N
    In Vivo; 2013; 27(1):57-60. PubMed ID: 23239852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for telomeric fusions as a mechanism for recurring structural aberrations of chromosome 11 in giant cell tumor of bone.
    Sawyer JR; Goosen LS; Binz RL; Swanson CM; Nicholas RW
    Cancer Genet Cytogenet; 2005 May; 159(1):32-6. PubMed ID: 15860354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.